首页> 外文OA文献 >Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis

【2h】

Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis

机译：单中心，非行动临床试验评估二维酮的医疗装置的安全性，疗效和可耐受性，以促进液态石病毒患者或牛皮癣患者的局部应用后的局部施用鳞片

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ulrich R. Hengge; Kristina Röschmann; Henning Candler;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis [J] . Ulrich R Hengge, Kristina R?schmann, Henning Candler Psoriasis: Targets and Therapy . 2017,第3期

机译：一项单中心，非介入性临床试验，旨在评估基于二甲双胍的医疗器械在局部应用银屑病或牛皮癣性头皮炎患者后促进清除水垢的安全性，有效性和耐受性
2. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis [J] . Bissonnette Robert, Pariser David M., Wasel Norman R., Journal of the American Academy of Dermatology . 2016,第1期

机译：口服磷酸二酯酶4抑制剂Apremilast在治疗掌足型牛皮癣中的应用：II期PSOR-005和III期疗效和安全性试验的合并分析结果，评估了Apremilast对银屑病（ESTEEM）在中度患者中的临床试验的效果重度牛皮癣
3. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis [J] . Bissonnette Robert, Pariser David M., Wasel Norman R., Journal of the American Academy of Dermatology . 2016,第1期

机译：Apremilast，一种口服磷酸二酯酶-4抑制剂，治疗棕榈术牛皮癣：来自II期PSOR-005和III期疗效和安全试验的汇总分析的结果评估中度患者患者的牛皮癣（尊重）临床试验的影响对严重的牛皮癣
4. Single-center noninterventional clinical trial to assess the safety efficacy and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis [O] . Ulrich R Hengge, Kristina Röschmann, Henning Candler 2017

机译：一项单中心非介入性临床试验用于评估基于二甲双胍的医疗器械在局部应用银屑病或牛皮癣性头皮炎患者后促进清除水垢的安全性有效性和耐受性
5. Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis [O] . D Roblin, G Yosipovitch, B Boyce, 2015

机译：局部Trka激酶抑制剂CT327是一种有效的新疗法，用于治疗瘙痒症，由于牛皮癣：实验研究的结果，CT327在牛皮癣患者的2B期临床试验中的实验研究和CT327的疗效和安全性

Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis

著录项

相似文献

相关主题

期刊订阅